ENTERO Vu 24% 240 mg/mL

ENTERO Vu 24% 240 mg/mL is a barium sulfate suspension used for medical imaging. This oral suspension aids in visualizing the gastrointestinal tract, providing clear images for diagnostic purposes.

ENTERO Vu 24% 240 mg/mL is primarily used as a contrast agent for X-ray imaging of the gastrointestinal tract. It helps enhance the visibility of the digestive system, allowing healthcare professionals to assess its structure and function. This suspension is commonly administered orally to facilitate detailed imaging, aiding in the diagnosis of various gastrointestinal conditions.

When taken as directed, ENTERO Vu 24% 240 mg/mL may cause temporary changes in bowel movements or mild gastrointestinal discomfort. Some individuals might experience bloating or a feeling of fullness. These effects are generally short-lived and subside once the procedure is complete.

It is important to follow the instructions provided by your healthcare professional when using ENTERO Vu 24% 240 mg/mL. Inform your healthcare provider about any allergies or medical conditions before administration. Ensure proper storage and handling to maintain the integrity of the suspension.

ENTERO Vu 24% 240 mg/mL may interact with certain medications or supplements. It is advisable to discuss your current medications with your healthcare provider to avoid potential interactions. Additionally, avoid consuming foods or beverages that could interfere with the imaging process.